Technologies Available for License : Vaccine Adjuvants
Use of Interleukin 7 to Improve Vaccine Potency
Tech ID: 01-93-05
Technology Description:
The present invention is directed to a method of improving the potency of a vaccine in a mammalian host comprising administering a therapeutically effective amount of a vaccine and a potency improving amount of IL-7. In a preferred embodiment, the IL-7 is dissolved or dispersed in a pharmaceutically acceptable carrier. The pharmaceutically acceptable carrier is preferably in the form of a lipid dispersion.
Technology Offer:
The Washington Research Foundation is seeking commercial partners to develop
therapeutics based on the technology. License or option arrangements are
negotiable. US rights to the technology are available.
Patents/Publications:
Patents covering this technology include United States Patent No. 5,714,141,
which issued in February 1998.
For additional information, please contact:
Beth G. Etscheid, Ph.D.
Director of Licensing
Washington Research Foundation
2815 Eastlake Avenue E, Suite 300
Seattle, WA 98102
Tel: 206.336.5600
Fax: 206.336.5615
betschei@wrfseattle.org